03 May 2021
31 May 2021
28 May 2021
Integrated Community Pharmacy Agreement Contracts
In response to your request under the Official Information Act, please find our response below:
I am writing to request some information in regard to the issuing of integrated community
pharmacy service agreement (ICPSA).
How many ICPSA contracts are there in the BOP DHB?
How many new ICPSA contracts have been issued since the ICPSA was implemented
on 1/10/18? (not including and previous holders of a CPSA prior to ICPSA on 1/10/18)
Of the new ICPSA issued since 1/10/18, how may have been located within 800m of
an existing pharmacy holding an ICPSA?
Is there a moratorium in place within the BOP DHB that could potentially restrict the
number of new ICPSA issued?
What criteria(s) would allow the DHB to decline issuing an ICPSA?
How many ICPSA applications have been turned down by the DHB since the 1/10/18
and any justification for rejecting the application?
There are 57 Integrated Community Pharmacy Services (ICPSA) contracts in BOPDHB.
There have been 18 new ICPSA contract issued since 1 October 2018.
The DHB does not know the exact distance from a new pharmacy, within the requested
date range, to existing ones, but prescribed distance (800m) is not a criterion in the DHB
policy or application form. The DHB knows of one pharmacy, with a new Integrated
Community Pharmacy Services Agreement (ICPSA) issued since 1 October 2018 which
may fit into the distance quoted by the enquirer.
Every ICPSA application is unique and several factors relating to distance would be
considered e.g. new location in a busy mall with high foot traffic or increasing populations
due to new housing and inner-city intensification e.g. apartments. These factors would
likely lead to greater demand.
The DHB does have a policy and application process in place since 1 October 2019.
The DHB does not use the policy as a restrictive
mechanism for the number of pharmacies. The DHB approach is to ensure the
population has access to high quality pharmacy services close to home and to ensure
sustainability of high-quality pharmacy services.
Any new application is unique, and all factors would be considered. The DHB would not
issue a ICPSA to a new pharmacy without a License to Operate, without proven
adequate staffing levels, where the pharmacy owner has a serious past with pharmacy
ownership and Medsafe raised concerns. It is possible the DHB may not issue a ICPSA
if the value add to the population was not demonstrated e.g. extended hours or if the
proposed new pharmacy was located with a significant amount of other pharmacies in
very close location, likely to render sustainability issues and affecting population
services. However, these matters would be considered in light of the overall application.
No ICPSA applications have been declined since 1 October 20218. Please note the
DHB policy came into ef ect 1 October 20219. There has only been one application
since that date which was successful.
Please note that this response may be published on our website as part of our proactive
Senior Advisor Governance and Quality